These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 494257)

  • 21. Reciprocal gastropancreatic modulations for the release of somatostatin-like immunoreactivity, glucagon, and insulin in the rat.
    Marre M; Miller J; Helman AM; Assan R
    Diabetes; 1983 Aug; 32(8):768-73. PubMed ID: 6347773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucagon deficiency and hyperaminoacidemia after total pancreatectomy.
    Boden G; Master RW; Rezvani I; Palmer JP; Lobe TE; Owen OE
    J Clin Invest; 1980 Mar; 65(3):706-16. PubMed ID: 6986412
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glucagon suppression improves glucoregulation in moderate but not chronic severe diabetes.
    Lickley HL; Kemmer FW; Doi K; Vranic M
    Am J Physiol; 1983 Oct; 245(4):E424-9. PubMed ID: 6137957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute effects of distal pancreatectomy on portal and peripheral blood insulin concentrations in patients undergoing total gastrectomy.
    Hayakawa J; Tsuburaya A; Motohashi H; Sairenji M; Kobayashi O; Suzuki K; Usuda Y
    Surg Today; 1998; 28(4):363-6. PubMed ID: 9590698
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of total pancreatectomy on the secretion of gut glucagon in humans.
    Yasui K
    Jpn J Surg; 1983 Mar; 13(2):122-9. PubMed ID: 6350663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of response of gut GLI to fat ingestion in dogs.
    Ohneda A; Kobayashi T; Nihei J
    Horm Metab Res; 1984 Dec; 16 Suppl 1():105-9. PubMed ID: 6398248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucagon secretory responses to insulin-induced hypoglycemia and arginine in streptozotocin-induced diabetic dogs.
    Gotoh M; Okamura J; Monden M; Shima K
    Endocrinol Jpn; 1983 Aug; 30(4):443-50. PubMed ID: 6368206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gastric A-cell function in insulin-deprived depancreatized dogs.
    Blazquez E; Muñoz-Barragan L; Patton GS; Orci L; Dobbs RE; Unger RH
    Endocrinology; 1976 Nov; 99(5):1182-8. PubMed ID: 991814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Splanchnic glucagon kinetics in exercising alloxan-diabetic dogs.
    Coker RH; Lacy DB; Krishna MG; Wasserman DH
    J Appl Physiol (1985); 1999 May; 86(5):1626-31. PubMed ID: 10233127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Change of glucagon reacting to 30 K antibody in totally depancreatized dogs.
    Sudo T; Konishi K; Nakase A; Suzuki T; Nishimura I; Tobe T
    Gastroenterol Jpn; 1978; 13(2):119-26. PubMed ID: 669196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glucoregulation in alloxan-diabetic dogs.
    Lussier B; Vranic M; Kovacevic N; Hetenyi G
    Metabolism; 1986 Jan; 35(1):18-24. PubMed ID: 3510360
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Demonstration of gastric glucagon hypersecretion in insulin-deprived alloxan-diabetic dogs.
    Blazquez E; Muñoz-Barragan L; Patton GS; Dobbs RE; Unger RH
    J Lab Clin Med; 1977 May; 89(5):971-7. PubMed ID: 870572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extrapancreatic glucagon and glucagonlike immunoreactivity in depancreatized dogs. A quantitative assessment of secretion rates and anatomical delineation of sources.
    Muller WA; Girardier L; Seydoux J; Berger M; Renold AE; Vranic M
    J Clin Invest; 1978 Jul; 62(1):124-32. PubMed ID: 659625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Measurement and partial characterization of immunoreactive glucagon in gastrointestinal tissues of dogs.
    Morita S; Doi K; Yip CC; Vranic M
    Diabetes; 1976 Nov; 25(11):1018-25. PubMed ID: 186345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Response of gastric inhibitory polypeptide (GIP) to oral administration of nutrients in normal and pancreatectomized dogs.
    Ohneda A; Kobayashi T; Nihei J
    Regul Pept; 1983 Feb; 5(3):263-72. PubMed ID: 6342065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Influence of total pancreatectomy on the secretion of human growth hormone and the endocrine pancreas].
    Takaesu Y; Nimura Y; Hayakawa N; Yasui K; Ohtsuka K
    Nihon Geka Gakkai Zasshi; 1988 Oct; 89(10):1686-91. PubMed ID: 3059167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pancreatic A-cell function in the partially pancreatectomized Otsuka Long-Evans Tokushima Fatty rat, a model of spontaneous non-insulin-dependent diabetes mellitus.
    Zhu M; Mizuno A; Noma Y; Sano T; Shima K
    Metabolism; 1996 Nov; 45(11):1360-7. PubMed ID: 8931640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The essentiality of insulin and the role of glucagon in regulating glucose utilization and production during strenuous exercise in dogs.
    Vranic M; Kawamori R; Pek S; Kovacevic N; Wrenshall GA
    J Clin Invest; 1976 Feb; 57(2):245-55. PubMed ID: 1254723
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of glicentin-related peptides upon the secretion of insulin and glucagon in the canine pancreas.
    Ohneda A; Ohneda M
    Tohoku J Exp Med; 1988 Jun; 155(2):197-204. PubMed ID: 3062845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of glucagon in the pathogenesis of the endogenous hyperglycemia of diabetes mellitus.
    Sakurai H; Dobbs RE; Unger RH
    Metabolism; 1975 Nov; 24(11):1287-97. PubMed ID: 1186499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.